Got A Tip?

Star Seeker

Drugs

Kim Kardashian Is Once Again Trying To Sell You Morning Sickness Pills Two Years After She Was Shut Down By The FDA!

no title
Geesh, how much is this company paying her??
Back in 2015, Kim Kardashian posted a sponsored ad on her Instagram for Diclegis, a medication aimed at treating morning sickness.
Related: Kim Admits To Sucking In Her Stomach To Hide Pregnancy!!
Almost a month later, the KUWTK star was forced to take down the post because the Food and Drug Administration found her endorsement to be “misleading,” and failed “to communicate any risk information.”
Fast forward to Thursday, Kanye West‘s wife is promoting the drug ONCE AGAIN even after going through the controversy!
The 36-year-old added the (above) photo with the caption:

“Remember this? Just want to remind all of you that if you’re miserable with #morningsickness like I was, try changing your diet & lifestyle first. If you still feel sick, don’t wait-ask your doctor about #Diclegis (doxylamine succinate & pyridoxine HCl), the only FDA-approved medication for morning sickness. It’s the most studied drug in pregnancy & it worked for me! I want to empower all moms-to-be and encourage them to speak up. #DontSufferInSilence! The most common side effect is drowsiness.”

Unlike last time, Kimmy was prepared and listed the medication’s safety information. You can see the full post HERE!
However, this isn’t the first time a celeb has endorsed a questionable product! To see the entire list:
CLICK HERE to view “Here Are All The Questionable Products Your Favorite Celebrities Endorse”
CLICK HERE to view “Here Are All The Questionable Products Your Favorite Celebrities Endorse”
CLICK HERE to view “Here Are All The Questionable Products Your Favorite Celebrities Endorse”
CLICK HERE to view “Here Are All The Questionable Products Your Favorite Celebrities Endorse”
CLICK HERE to view “Here Are All The Questionable Products Your Favorite Celebrities Endorse”
[Image via Kim Kardashian/Instagram.]

Related Posts

CLICK HERE TO COMMENT
Apr 13, 2017 21:53pm PDT